SGN-LIV1A: a development stage antibody drug-conjugate targeting LIV-1 for the treatment of metastatic breast cancer.

被引：3

作者：

Sussman, Django ^{[1
]}

Smith, Leia M. ^{[1
]}

Anderson, Martha E. ^{[1
]}

Duniho, Steve ^{[1
]}

Hunter, Joshua H. ^{[1
]}

Kostner, Heather ^{[1
]}

Miyamoto, Jamie B. ^{[1
]}

Nesterova, Albina ^{[1
]}

Westendorf, Lori ^{[1
]}

Van Epps, Heather A. ^{[1
]}

Whiting, Nancy ^{[1
]}

Benjamin, Dennis R. ^{[1
]}

机构：

[1] Seattle Genet, Bothell, WA USA

来源：

CANCER RESEARCH | 2013年 / 73卷 / 08期

关键词：

D O I：

10.1158/1538-7445.AM2013-3962

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3962

引用

页数：1

共 50 条

[41] Targeting cell adhesion molecule 1 (CADM1) with an antibody drug conjugate for the treatment of osteosarcoma
Wang, Yifei
Zhang, Zhongting
Zhang, Wendong
Tian, Xiangjun
Lazcano, Rossana
Roth, Michael
Gill, Jonathan
Harrison, Douglas
Xu, Zhaohui
Tu, Yizheng
Jusu, Sylvester
Longo, Giuseppe
Zhou, Xin
Wang, Jing
Gorlick, Richard
CANCER RESEARCH, 2023, 83 (07)
[42] Trastuzumab emtansine, an antibody-drug conjugate for the treatment of HER2+metastatic breast cancer
Niculescu-Duvaz, Ion
CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2010, 12 (03) : 350 - 360
[43] Antibody-drug conjugates targeting DDR1 as a novel strategy for treatment of breast cancer
Tao, Yiran
Lu, Ying
Xue, Ting
Lai, Qinhuai
Song, Hengrui
Chen, Xiaofeng
Guo, Cuiyu
Yang, Jinliang
Wang, Yuxi
JOURNAL OF DRUG TARGETING, 2024, 32 (10) : 1295 - 1304
[44] A Mechanistic Pharmacokinetic Model Elucidating the Disposition of Trastuzumab Emtansine (T-DM1), an Antibody–Drug Conjugate (ADC) for Treatment of Metastatic Breast Cancer
Brendan Bender
Douglas D. Leipold
Keyang Xu
Ben-Quan Shen
Jay Tibbitts
Lena E. Friberg
The AAPS Journal, 2014, 16 : 994 - 1008
[45] Antibody-drug conjugates targeting TROP-2: Clinical development in metastatic breast cancer
Shastry, Mythili
Jacob, Saya
Rugo, Hope S.
Hamilton, Erika
BREAST, 2022, 66 : 169 - 177
[46] Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate
Phillips, Gail D. Lewis
Li, Guangmin
Dugger, Debra L.
Crocker, Lisa M.
Parsons, Kathryn L.
Mai, Elaine
Blattler, Walter A.
Lambert, John M.
Chari, Ravi V. J.
Lutz, Robert J.
Wong, Wai Lee T.
Jacobson, Frederic S.
Koeppen, Hartmut
Schwall, Ralph H.
Kenkare-Mitra, Sara R.
Spencer, Susan D.
Sliwkowski, Mark X.
CANCER RESEARCH, 2008, 68 (22) : 9280 - 9290
[47] SGN-PDL1V, A NOVEL, INVESTIGATIONAL PD-L1-DIRECTED ANTIBODY-DRUG CONJUGATE FOR THE TREATMENT OF SOLID TUMORS
Kwan, Byron
Ramirez, Megan
Jin, Steven
Yu, Changpu
Wo, Serena
Gupta, Priyanka
Allred, Sean
Simmons, Jessica
Hensley, Kelly
de Zafra, Christina Zuch
Neff-LaFord, Haley
Hengel, Shawna
Forero-Torres, Andres
Van Epps, Heather
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A818 - A818
[48] HER2-targeting antibody drug conjugate FS-1502 in HER2-expressing metastatic breast cancer: a phase 1a/1b trial
Li, Qiao
Cheng, Ying
Tong, Zhongsheng
Liu, Yunjiang
Wang, Xian
Yan, Min
Chang, Jianhua
Wang, Shusen
Du, Caiwen
Li, Liang
Wu, Chunjiao
Wang, Mingxia
Wang, Zhuo
Wu, Zhuli
Wang, Xingli
Jin, Yongli
Diao, Lei
Sun, Yi
Zhang, Yongjiao
Hui, Ai-Min
Xu, Binghe
NATURE COMMUNICATIONS, 2024, 15 (01)
[49] Targeting kinome reprogramming in ESR1 fusion-driven metastatic breast cancer.
Gou, Xuxu
Kim, Beom-Jun
Anurag, Meenakshi
Holt, Matthew Valle
Young, Meggie Nguyen
Lei, Jonathan Thomas
Fandino, Diana
Vollert, Craig T.
Singh, Purba
Alzubi, Mohammad A.
Dobrolecki, Lacey Elizabeth
Lewis, Michael
Welm, Alana
Li, Shunqiang
Foulds, Charles Edward
Ellis, Matthew James
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[50] A novel humanized MUC1 antibody-drug conjugate for the treatment of trastuzumab-resistant breast cancer
Wu, Guang
Li, Lan
Qiu, Yuxin
Sun, Wei
Ren, Tianhao
Lv, Yingshuai
Liu, Mengnan
Wang, Xiaoxia
Tao, Hongqun
Zhao, Lingjie
Cao, Jiawei
He, Licai
Li, Hongzhi
Gu, Haihua
ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2021, 53 (12) : 1625 - 1639

← 1 2 3 4 5 →